What to watch with CYP2D6 and Haut?

The combination of CYP2D6 and skin is not specifically addressed in the provided knowledge context. CYP2D6 is a key enzyme metabolizing many drugs, including certain antidepressants, antipsychotics, beta-blockers, and opioids like codeine. For skin conditions, systemic medications such as some antihistamines (e.g., promethazine) or tamoxifen (used in hormone-sensitive skin tumors) may be affected. However, evidence for direct skin-related effects of CYP2D6 variants is weak. Most topical skin treatments are applied locally and undergo minimal first-pass metabolism. A CYP2D6 poor metabolizer may experience higher plasma levels of systemic drugs, increasing side effect risk, while ultrarapid metabolizers may have reduced efficacy. Without specific studies linking CYP2D6 to skin outcomes, the statement remains general. Consult a physician or pharmacist before changing medications based on your genotype. Evidence is rated as unclear due to lack of specific sources.